These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12753767)

  • 1. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Filipović-Grcić J; Voinovich D; Moneghini M; Becirevic-Lacan M; Magarotto L; Jalsenjak I
    Eur J Pharm Sci; 2000 Feb; 9(4):373-9. PubMed ID: 10664477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine serum albumin nanospheres carrying progesterone inclusion complexes.
    Luppi B; Cerchiara T; Bigucci F; Caponio D; Zecchi V
    Drug Deliv; 2005; 12(5):281-7. PubMed ID: 16188727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
    Cavalli R; Peira E; Caputo O; Gasco MR
    Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO; Mahaguna V; Sriwongjanya M
    Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
    Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
    Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.
    Jafar M; Khalid MS; Alghamdi H; Amir M; Al Makki SA; Alotaibi OS; Al Rmais AA; Imam SS; Alshehri S; Gilani SJ
    AAPS PharmSciTech; 2022 Feb; 23(2):71. PubMed ID: 35146576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
    Ansari MT; Iqbal I; Sunderland VB
    Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
    Fini A; Ospitali F; Zoppetti G; Puppini N
    Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
    Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.